Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05485675 · ClinicalTrials.gov registry record · NA
Stand & Move at Work II: Effectiveness and Implementation of a Worksite Wellness Program
A NA study of Sedentary Behavior, sponsored by Arizona State University.
- Recruiting
- Registry status
- NA
- Development phase
- 4,800
- Enrollment target
- 1
- Study location
NCT05485675: Recruiting NA study of Sedentary Behavior, sponsored by Arizona State University.
NCT05485675 is a NA study of Sedentary Behavior that is actively recruiting participants, run by Arizona State University. The registered enrollment target is 4,800 participants, above the 643-participant average among 42 other Sedentary Behavior trials with a reported enrollment target (647% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05485675, a NA study of Sedentary Behavior, is actively recruiting participants, sponsored by Arizona State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 4,800 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a 2-arm group-randomized hybrid effectiveness-implementation (HEI type 2) study to test an evidence-based intervention (EBI) known as Stand \& Move at Work(SMW) to reduce sedentary time in the workplace, and to test the role of expert facilitation (SMW+) for improving intervention fidelity.
Primary Outcome
Accelerometer-based (activPAL) sensor fixed to the thigh that measures sitting, standing, and lying down over 7 days.
Conditions Studied
Interventions
- BEHAVIORAL Stand & Move at Work
- BEHAVIORAL Stand & Move at Work+
Study Locations (1)
Arizona
- Arizona State University College of Health Solutions - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,800 participants |
| Start Date | 2022-10-07 |
| Est. Completion | 2027-02-28 |
| Phase | NA |
What NCT05485675 shows while recruiting
NCT05485675 is an interventional study that assigns participants to a tested intervention. Its 4,800 participants enrollment target places it among the larger protocols in the corpus, above the 643-participant average among 42 other Sedentary Behavior trials with a reported enrollment target (647% higher).
The record links to 1 condition, with Sedentary Behavior appearing as the primary indexed condition, and to 2 interventions - of which Stand & Move at Work is the first listed.
NCT05485675 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT05485675 about?
NCT05485675 is a clinical study titled "Stand & Move at Work II: Effectiveness and Implementation of a Worksite Wellness Program". This is a 2-arm group-randomized hybrid effectiveness-implementation (HEI type 2) study to test an evidence-based intervention (EBI) known as Stand \& Move at Work(SMW) to reduce sedentary time in the workplace, and to test the role of expert facilitation (SMW+) for improving intervention fidelity.
What is the current status of trial NCT05485675?
This trial is currently recruiting. It is a NA study. The enrollment target is 4,800 participants. The study started on 2022-10-07. Estimated completion is 2027-02-28.
What conditions does trial NCT05485675 study?
This clinical trial studies the following conditions: Sedentary Behavior.
What interventions are being tested in trial NCT05485675?
The interventions under investigation include: Stand & Move at Work (BEHAVIORAL), Stand & Move at Work+ (BEHAVIORAL).
Who is sponsoring clinical trial NCT05485675?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05485675 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sedentary Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05485675's enrollment target sits among peer trials
4,800 2nd of 42 the highest of 42 other Sedentary Behavior trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sedentary Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Teen Mom Study Feasibility Trial
RECRUITING · NA
-
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
RECRUITING · NA
-
Promoting Physical Activity in Older Hispanic/Latino(a) Adults
RECRUITING · NA
-
Sitting Interruption and Whole-body Cardiovascular Health
RECRUITING · NA
-
The Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older Adults
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01719055 · 4,800 participants
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
- NCT06307652 · 4,800 participants · Phase 3
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- NCT05252754 · 4,874 participants · Phase 3
Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis
- NCT05929976 · 4,900 participants
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI